和元生物
(688238)
| 流通市值：50.89亿 | | | 总市值：51.01亿 |
| 流通股本：6.47亿 | | | 总股本：6.49亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 178,354,231.68 | 150,737,228.45 | 292,589,938.14 | 238,694,510.77 |
| 交易性金融资产 | 18,029,623.99 | 50,218,826.4 | - | 50,002,454.99 |
| 应收票据及应收账款 | 108,550,459.78 | 95,890,358.59 | 93,591,540.39 | 82,023,646.74 |
| 其中：应收票据 | - | - | - | 1,453,500 |
| 应收账款 | 108,550,459.78 | 95,890,358.59 | 93,591,540.39 | 80,570,146.74 |
| 预付款项 | 6,811,986.73 | 6,769,905.96 | 5,823,386.73 | 8,923,964.84 |
| 其他应收款合计 | 3,166,383.05 | 3,079,962.24 | 2,055,301.3 | 2,426,851.43 |
| 存货 | 81,712,135.49 | 77,202,295.45 | 69,121,723.17 | 78,766,913.8 |
| 合同资产 | 26,758,007.57 | 31,315,044.42 | 26,507,558.14 | 23,685,961.98 |
| 其他流动资产 | 59,808,194.42 | 58,178,426.44 | 57,465,951.75 | 52,327,773.1 |
| 流动资产合计 | 483,191,022.71 | 473,392,047.95 | 547,155,399.62 | 536,852,077.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 57,482,664.91 | 58,012,117.66 | 56,757,899.03 | 62,567,560.19 |
| 其他权益工具投资 | 70,669,912.19 | 70,669,912.19 | 70,669,912.19 | 64,669,912.19 |
| 固定资产 | 1,270,626,675.09 | 1,284,470,165.01 | 1,304,329,655.28 | 1,301,109,834.84 |
| 在建工程 | 22,444,783.5 | 11,738,255.49 | 10,612,081.12 | 49,536,746.71 |
| 使用权资产 | 10,625,250.73 | 11,844,286.63 | 13,063,322.53 | 14,282,358.43 |
| 无形资产 | 55,039,847.66 | 55,464,731.14 | 55,834,555.29 | 53,787,342.47 |
| 长期待摊费用 | 831,708.81 | 1,511,842.2 | 2,191,975.59 | 2,872,108.98 |
| 递延所得税资产 | 30,238,571.79 | 31,074,888.09 | 31,177,347.27 | 31,293,770.11 |
| 非流动资产合计 | 1,517,959,414.68 | 1,524,786,198.41 | 1,544,636,748.3 | 1,580,119,633.92 |
| 资产总计 | 2,001,150,437.39 | 1,998,178,246.36 | 2,091,792,147.92 | 2,116,971,711.57 |
| 流动负债: | | | | |
| 短期借款 | 175,106,475.02 | 165,086,028.05 | 250,166,986.12 | 244,653,985.94 |
| 应付票据及应付账款 | 64,281,802 | 64,746,399.68 | 95,295,914.06 | 106,264,585.82 |
| 其中：应付票据 | 3,153,542.65 | - | - | - |
| 应付账款 | 61,128,259.35 | 64,746,399.68 | 95,295,914.06 | 106,264,585.82 |
| 合同负债 | 55,498,299.24 | 33,526,278.76 | 32,523,234.97 | 34,077,482.97 |
| 应付职工薪酬 | 19,098,165.26 | 21,924,155.46 | 27,145,681.48 | 12,419,210.53 |
| 应交税费 | 2,618,057.41 | 3,068,786.58 | 4,321,978.84 | 2,917,039.05 |
| 其他应付款合计 | 8,201,319.26 | 8,059,728.57 | 7,679,416.01 | 7,862,997.02 |
| 一年内到期的非流动负债 | 70,882,343.11 | 70,393,973.54 | 24,856,079.05 | 20,308,131.83 |
| 其他流动负债 | 3,488,206.66 | 2,100,313.25 | 1,964,270.18 | 2,077,225.79 |
| 流动负债合计 | 399,174,667.96 | 368,905,663.89 | 443,953,560.71 | 430,580,658.95 |
| 非流动负债: | | | | |
| 长期借款 | 199,237,000 | 173,870,500 | 136,354,000 | 110,587,500 |
| 租赁负债 | 6,124,446 | 7,602,688.71 | 9,064,996.85 | 10,516,197.9 |
| 预计负债 | 16,304,209.18 | 17,757,540.68 | 19,853,890.18 | 21,375,121.5 |
| 递延收益 | 68,085,164.03 | 69,688,143.64 | 71,194,705.29 | 59,070,735.82 |
| 递延所得税负债 | 2,659,175.08 | 2,968,309.44 | 3,265,830.63 | 3,570,589.61 |
| 非流动负债合计 | 292,409,994.29 | 271,887,182.47 | 239,733,422.95 | 205,120,144.83 |
| 负债合计 | 691,584,662.25 | 640,792,846.36 | 683,686,983.66 | 635,700,803.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 649,036,700 | 649,036,700 | 649,036,700 | 649,036,700 |
| 资本公积 | 1,451,253,618.89 | 1,450,523,593.38 | 1,449,738,623.83 | 1,449,998,866.09 |
| 减:库存股 | 99,998,582.03 | 99,998,582.03 | 99,998,582.03 | 99,943,885.46 |
| 其他综合收益 | 210,454.71 | 265,383.02 | 355,763.15 | 413,942.35 |
| 盈余公积 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 |
| 未分配利润 | -701,763,008.4 | -653,433,762.62 | -600,348,938.21 | -527,399,832.49 |
| 归属于母公司股东权益合计 | 1,308,053,097.06 | 1,355,707,245.64 | 1,408,097,480.63 | 1,481,419,704.38 |
| 少数股东权益 | 1,512,678.08 | 1,678,154.36 | 7,683.63 | -148,796.59 |
| 股东权益合计 | 1,309,565,775.14 | 1,357,385,400 | 1,408,105,164.26 | 1,481,270,907.79 |
| 负债和股东权益合计 | 2,001,150,437.39 | 1,998,178,246.36 | 2,091,792,147.92 | 2,116,971,711.57 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-21 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |